Validation of a Simplified Severity Score (Investigator Global Assessment:

See also
Status	Clinical Trial	Phase
Terminated	`NCT03286582` - A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous Pemphigoid	Phase 2
Completed	`NCT02837965` - Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid
Recruiting	`NCT03636763` - Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?
Recruiting	`NCT00802243` - Leflunomide Associated With Topical Corticosteroids for Bullous Pemphigoid	Phase 2
Completed	`NCT05649579` - Efficacy and Safety of Dupilumab in Patients With Bullous Pemphigoid
Active, not recruiting	`NCT04206553` - A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid	Phase 2/Phase 3
Completed	`NCT00431119` - Azathioprine or Mycophenolate Mofetil for Bullous Pemphigoid	Phase 2
Completed	`NCT04563923` - Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody	Phase 2
Completed	`NCT03320798` - Impact of Neurological Diseases on the Prognosis of Bullous Pemphigoid: A Retrospective Study of 178 Patients	N/A
Completed	`NCT03272958` - Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous Pemphigoid
Completed	`NCT02883894` - Interest of Dosage of Anti-PB230, Anti-PB180 and Cytokines for Monitoring of Patients Suffering From Bullous Pemphigoid	N/A
Completed	`NCT00809822` - Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids.	Phase 2
Recruiting	`NCT05594472` - Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid	Phase 3
Withdrawn	`NCT05061771` - Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP)	Phase 3
Not yet recruiting	`NCT04128176` - Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous Pemphigoid	Phase 3
Recruiting	`NCT05284929` - Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian Population
Terminated	`NCT04612790` - A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.	Phase 3
Recruiting	`NCT05681481` - A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid	Phase 3
Completed	`NCT00286325` - Rituximab in the Treatment of Patients With Bullous Pemphigoid	Phase 1/Phase 2
Completed	`NCT04728854` - Telederm and Bullous Pemphigoid

NCT number	NCT05366127
Study type	Observational
Source	University Hospital, Rouen
Contact	Pascal JOLY, Pr
Phone	+3323288
Email	pascal.joly@chu-rouen.fr
Status	Not yet recruiting
Phase
Start date	July 1, 2022
Completion date	July 30, 2026

Validation of a Simplified Severity Score (Investigator Global Assessment: IGA) in Bullous Pemphigoid — IGA score

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms